SmithSolve

SmithSolve is a healthcare communications agency based in Morristown, United States, founded in 2006. The agency provides strategic public relations, corporate communications, and patient advocacy services, primarily serving biopharmaceutical companies. With a team of around 25 employees, SmithSolve focuses on helping clients navigate the complexities of drug development and commercialization, particularly for rare diseases and orphan drugs. The agency operates within a global network of healthcare communications partners spanning more than 50 countries.

Services and Specialties

SmithSolve offers a range of tailored communications services designed to support biopharmaceutical firms throughout the drug development lifecycle. The agency's core capabilities include communications strategy, message development, corporate branding, and media relations. They also provide specialized services such as clinical data announcements, issues management, and science translation, which help translate complex scientific information into accessible content for various audiences. Additionally, SmithSolve develops disease awareness campaigns, patient stories, and patient-centered communication initiatives. Their digital offerings encompass social media strategy, website development, and data and insights. The agency also supports employee engagement and corporate communications programs. Key services include:

• Communications strategy and message development
• Corporate branding and media relations
• Clinical data announcements and science translation
• Patient advocacy and rare disease advocacy
• Disease awareness campaigns and patient stories
• Issues management and crisis communications
• Digital strategy, social media, and website development
• Medical communications and medical education
• Employee engagement and corporate communications

Clients and Industries Served

SmithSolve primarily works with biopharmaceutical companies, with a strong emphasis on rare disease and orphan drug developers. The agency supports clients across the drug development process, from early-stage research through clinical trials, regulatory approvals, and market access. They also serve healthcare organizations, patient advocacy groups, and B2B companies within the healthcare sector. SmithSolve's expertise in patient-centered communication and disease awareness campaigns makes them particularly suited for clients seeking to build trust and foster relationships with patients and caregivers. The agency's global network allows them to support multinational communications initiatives, reaching audiences in more than 50 countries.

Approach and Philosophy

SmithSolve integrates scientific, medical, and emotional aspects into their communications, aiming to build trust and foster meaningful patient relationships. The agency's approach involves developing tailored strategies that address each client's unique challenges, whether managing risk during drug development, communicating clinical data, or launching disease awareness campaigns. SmithSolve emphasizes patient advocacy and engagement, often working with patient advisory boards to ensure that messaging resonates with the intended audience. The agency's leadership, including President and CEO Chris Smith and Executive Vice President Katie Burns, brings extensive experience in health communications and integrated marketing. This experience helps SmithSolve guide clients through complex regulatory and reputational landscapes, ensuring that communications are both accurate and compelling.

Location and Credentials

Headquartered at 16 Washington St in Morristown, New Jersey, United States, SmithSolve operates from a central location in the New York metropolitan area. The agency's Morristown base provides access to a large pool of healthcare and pharmaceutical talent, as well as proximity to many of its biopharmaceutical clients. Founded in 2006, SmithSolve has built a reputation for specialized healthcare communications, particularly in the rare disease space. The agency's membership in a global healthcare communications network extends its reach and capabilities, allowing it to support clients with international campaigns and multi-market initiatives. SmithSolve is well-suited for biopharmaceutical companies, especially those focused on rare diseases, orphan drugs, or patient-centered communications, as well as healthcare organizations seeking strategic public relations and corporate communications support.